Close

Roth/MKM Starts Aslan Pharma (ASLN) at Buy, 'More Than Just Skin Deep'

May 30, 2023 4:33 PM EDT Send to a Friend
(Updated - May 30, 2023 4:34 PM EDT)

Roth/MKM analyst Dylan Dupuls initiates coverage on Aslan Pharma (NASDAQ: ASLN) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login